LGALS4 and Alzheimer disease: As shown in Figure 2C, the DI-treated flies representing AD exhibited an extremely reduced ability to climb compared to the AD-free flies (elav-GAL4), suggesting severe locomotory coordination possibly from high amounts of Aβ1–42 peptides (Figure 2B).